Vida 5Alternative Names: Vida-5
Latest Information Update: 05 Aug 2016
At a glance
- Originator Vidasym
- Mechanism of Action Calcitriol receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Renal failure
Most Recent Events
- 05 Aug 2016 No recent reports on development identified - Preclinical for Renal failure in USA (unspecified route)